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A B S T R A C T
Blepharis maderaspatensis (L.) B. Heyne ex Roth, Acanthaceae, is a procumbent or scrambling 
perennial herb used traditionally for treatment of snakebites, wounds, edema and gout. The 
anti-inflammatory and anti-nociceptive properties of the ethanol extract of the whole plant 
of B. maderaspatensis was investigated using carrageenan-induced paw edema in rats, xylene-
induced edema in mice, mouse writhing and tail clip tests respectively. The effect of the 
extract on inflammatory mediators, serotonin and histamine, using the most active dose 
(75 mg/kg) was also carried out. The results showed that the extract of B. maderaspatensis in 
carrageenan-induced test caused a significant inhibition (84.5%, 90 min) of paw edema at a 
dose of 75 mg/kg while the xylene-induced test caused a significant inhibition (62.65%) at 
50 mg/kg. The histamine-induced test showed significant inhibition (90.9%, 90 min) while 
serotonin-induced test showed moderate inhibition (54.10%, 180 min). In the mouse writhing 
and tail clip tests, the extract produced a significant inhibition of 66.21% and 15.81% at 75 
mg/kg, respectively. These results collectively demonstrate that the ethanol extract of B. 
maderaspatensis possesses anti-inflammatory and anti-nociceptive properties, and this 
supports the ethnopharmacological use of the plant in the treatment of inflammation.
© 2013 Elsevier Editora Ltda. 
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Introduction
Inflammation is a fundamental defensive reaction of the body 
to an invasion of pathogens or injury. It involves a complex 
array of enzyme activation; mediators release, extravasation, 
cell migration, tissue breakdown and repair (Vane and Bolting, 
1995). The classic signs of inflammation such as pain, redness, 
swelling and loss of function are produced by inflammatory 
agents such as nitric oxide, prostaglandins, bradykinin, 
serotonin, leukotrienes and histamine (Banasik, 2000; 
Chandrasoma and Taylor, 2005). Uncontrolled and persistent 
inﬂammation contributes to the progression of many chronic 
diseases such as multiple sclerosis, rheumatoid arthritis, 
atherosclerosis, psoriasis and inﬂammatory bowel disease 
(Talwar et al., 2011). Developments of new drugs with little or 
no side effects are still needed as some of the antiinflammatory 
drugs cause undesired and harmful effects. Nowadays, public 
interest in phytopharmaceuticals to inhibit chronic diseases 
is gathering momentum.
Open access under CC BY-NC-ND license.
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Blepharis maderaspatensis (L.) B. Heyne ex Roth (BM), a 
member of the family Acanthaceae, is a procumbent or 
scrambling perennial or rarely annual herb with stems up 
to 2.5 m long. It can be found in a wide variety of grassland, 
shrub and woodland habitats as well as forest-merging in the 
savannah zone, from Senegal to South Nigeria (Burkill, 1985). 
Traditionally it is used in treatment of swellings, edema and 
gout. A paste of the leaves is mixed with black gram powder, 
crushed onion and white egg yolk and the mixture is applied 
topically over fractured bones in Nigeria (Burkill, 2004). The 
whole plant is burnt to ash and mixed with oil for rubbing 
onto swollen legs after it has been washed in warm water in 
Tanganyika (Burkill, 1985). 
Although the cytotoxic activity against colon cancer cells, 
wound healing and antioxidant activities of the plant have 
been reported (Baskar et al., 2012; Rajasekaran et al., 2012), 
the anti-inflammatory and anti-nociceptive activities have 
not been scientifically confirmed. Hence, the present study 
aimed to evaluate the anti-inflammatory and anti-nociceptive 
activities of the ethanol extract of Blepharis maderaspatensis.
Materials and methods
Plant material and extraction
Fresh samples of Blepharis maderaspatensis (L.) B. Heyne ex 
Roth, Acanthaceae (whole plant), were collected from Odofin 
village in Ikire town, Osun State, Nigeria, and authenticated at 
the Herbarium of the Department of Botany and Microbiology 
where a voucher specimen was deposited (LUH 4592). The 
plant was dried in a hot air oven at 40 ºC and grounded in 
a mechanical grinder. The powdered material (500 g) was 
macerated with absolute ethanol for 72 h at room temperature. 
The extract was filtered and evaporated to dryness in a water 
bath at 40 °C. The percentage yield was 6.52% (w/w).
Animals
All the animals (male Wistar rats (100-200 g) and Swiss 
albino mice (20-30 g) used in this study were obtained from 
the National Agency for Food and Drugs Administration and 
Control, Yaba. The animals were kept in hygienic and well 
ventilated compartments and maintained under standard 
laboratory conditions (12 h light/dark cycle at 22 ± 2 °C) as 
approved by the Experimentation and Ethics Committee of 
the College of Medicine, University of Lagos (CM/COM/08). 
All animals were acclimatized for one week, fed rodent diet 
(Livestock Feeds PLC, Ibadan, Oyo State, Nigeria) and had free 
access to drinking water. They fasted for at least 12 h prior to 
experimentation.
Acute toxicity test
The method of Lorke (1983) was used with minor modifications 
for this study. A single oral dose of the extract (5 g/kg) was 
administered to a group of six healthy male mice the control 
group only received the vehicle (10 ml/kg, p.o.). The animals 
were observed for general behavioural changes, physiological 
function and mortality at 1, 4 and 24 h after treatment. The 
mice were further observed for up to seven days for any signs 
of delayed toxicity and mortality.
Anti-edematogenic models
Carrageenan-induced rat paw edema
In this assay, the rats were divided into seven groups (n 
= 6 each), which were orally treated with distilled water 
(control) or indomethacin (reference drug, 10 mg/kg), or the 
extract (12.5, 25, 50, 75 and 100 mg/kg). After 1 h after oral 
administration, 0.1 ml of 1% suspension of carrageenan in 
normal saline was injected into the sub-plantar tissue of the 
right hind paw to induce edema (Winter et al., 1962). The 
paw edema was measured at 30 min interval for 3 h after 
carrageenan injection. The linear paw circumference was 
measured using the cotton thread method of Bamgbose 
and Naomesi (1981). The difference between the initial and 
subsequent values gave the actual oedema value, which was 
compared to control. The inhibition of inflammation was 
calculated using the following formula:
 % inhibition=100 (Vc-  Vt )
                 Vc
where Vc represents mean edema in control and Vt mean 
edema in group treated with standard/extract. 
Histamine and serotonin-induced rat paw oedema
Three groups of six rats each were treated with the extract 
(75 mg/kg, p.o.), indomethacin (10 mg/kg, p.o.), and distilled 
water (10 ml/kg, p.o.). Paw edema was induced after 1 h by sub-
plantar administration of 0.1 ml histamine or serotonin (10-3 
mg/ml) on the right hand paw (Amann et al., 1995). The linear 
paw circumference was measured at 0 min and thereafter 
every 30 min for 3 h. 
 % inhibition=100 (Vc-  Vt )
                 Vc
where Vc represents mean edema in control and Vt mean 
edema in group treated with standard/extract. 
Xylene-induced ear edema
The animals were divided into five groups of six mice each. 
Edema was induced by applying 0.03 ml of xylene to the 
inner surface of the right ear 30 min after oral administration 
of distilled water (10 ml/kg), extract (12.5-100 mg/kg) and 
dexamethasone (1 mg/kg) respectively. The left ear was 
considered as control. Fifteen minutes after the application of 
xylene, the mice were killed under ether anesthesia and both 
ears were cut off and weighed (Nunez Guillen et al., 1997). The 
mean of the difference between the right and left ears was 
calculated.
 % inhibition=100 (Vc-  Vt )
                 Vc
where Vc represents difference in weight of ear in control and 
Vt difference in weight of ear in group treated with standard/
extract. 
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Anti-nociceptive activity 
Mouse writhing test
Mice divided into seven groups of six animals each were pre-
treated with distilled water (10 ml/kg, p.o.); extract (12.5-100 
mg/kg, p.o.) and acetylsalicylic acid (10 mg/kg, p.o.). After 1 h, 
the mice were injected with acetic acid (0.6% v/v in saline, 10 
ml/kg, i.p.). The number of writhing and stretching movements 
was counted for a period of 30 min (Koster et al., 1959). The 
percentage of anti-nociceptive activity was calculated as:
 % inhibition=100 (Vc-  Vt )
                 Vc
where Vc represents mean number of writhing in control and Vt 
mean number of writhing in group treated with standard/extract. 
Haffner’s tail clip test
In this model, a initial sensitivity test was carried out by 
applying a metal artery clip to the base of the tail to induce 
pain, animals that failed to attempt to dislodge the clip in 10 
s were discarded. The responsive mice were then divided into 
seven groups of six animals each. The pre-treatment reaction 
time of all mice was determined and treatment was then 
administered using distilled water (10 ml/kg, p.o.); extract 
(12.5-100 mg/kg, p.o.) and the standard drug, morphine (10 mg/
kg, s.c.). The reaction time of each animal was determined 60 
min post-treatment for oral administration and 30 min post-
treatment for subcutaneous administration (Adeyemi et al., 
2004; Bianchi and Franceschini, 1954). A post-treatment cut-off 
time of about 60 s was used.
100 x 
latency) treatmentPre -  timeoff-(Cut
latency) treatment(Pre - latency)treatment-(PostInhibition % 
Quantitative analysis
Determination of total phenolic content
The concentration of total phenolics in the ethanol extract of 
Blepharis maderaspatensis was determined by the Folin-Ciocalteu 
colorimetric method (Slinkard and Singleton, 1977). Brieﬂy, 500 
μl of the solution (containing 1 mg/ml) extract in methanol was 
added to 2.5 ml Folin-Ciocalteu reagent (diluted with water 1:1) 
and 2 ml (75 g/l) sodium carbonate. After 30 min of incubation at 
40 °C, the resulting absorbance was measured at 760 nm using 
a spectrophotometer (T80 spectrometer, PG Instrument Ltd.). 
A calibration curve, using gallic acid in a concentration range 
of 0.01-0.05 mg/ml was prepared. Measurements were carried 
out in triplicate. The total phenolic content was expressed as 
milligram gallic acid equivalent (GAE) per gram of sample.
Determination of total flavonoid content 
The total flavonoid content of the extract was determined 
using the method of (Ordonez et al., 2006). Quercetin was used 
as standard. Solution of 2% AlCl3 in ethanol (1 ml) was added to 
1 ml of the extract. The absorbance was measured at 420 nm 
after 1 h of incubation at room temperature. Measurements were 
carried out in triplicate. Total flavonoid content was expressed as 
milligram quercetin equivalent (QE) per gram of sample.
Statistical analysis
Data were presented at mean ± SEM. The data were analysed 
using GraphPad Prism for windows version 5 (GraphPad 
Software, San Diego, CA, USA). Values were considered 
significant when p ≤ 0.05.
Results
Acute toxicity test
Oral administration of BM extract at 5 g/kg did not produce any 
mortality. The extract did not produce significant changes in 
behavior during the time of observation.
Anti-inflammatory activity
Carrageenan-induced rat paw edema
The subplantar injection of carrageenan produced edema 
development which increased progressively with time in the 
control group. Peak edema development was observed at 180 
min (2.53 ± 0.15). The administration of BM (12.5, 25, 50 and 75 
mg/kg, p.o.) showed significant (p < 0.05) inhibition from 30 min 
after carrageenan injection with peak effect (84.5%) produced 
at the dose of 75 mg/kg at 90 min. Oral administration of 
indomethacin (10 mg/kg) also significantly (p < 0.01) reduced 
the edema with 86.7% inhibition at 180 min (Table 1). However 
pro-inflammatory activity was observed for the plant extract 
at 100 mg/kg.
Histamine and serotonin-induced rat paw edema
A significant (p < 0.001) reduction in the edema of mice treated 
with the extract was observed in the histamine-induced paw 
edema model (Fig. 1). The maximum inhibition was observed 
at 90 min (90.9%). 
In the serotonin-induced paw edema model, the extract had 
low effect on the inhibition of edema. The maximum inhibition 
was observed at 180 min (54.1%) (Fig. 1). 
Xylene-induced ear edema
The effect of B. maderaspatensis was dose-dependent with peak 
effect (62.65% inhibition) produced at the dose of 50 mg/kg 
(Table 2). This effect was greater than but not significantly 
(p < 0.05) different from that produced by dexamethasone 
(50.2% inhibition). Pro-inflammatory activity was also observed 
for the extract at 100 mg/kg.
Anti-nociceptive activity
Mouse writhing test
In this model, the oral administration of B. maderaspatensis 
produced a reduction in the number of writhes at all the five 
doses tested, but the maximum inhibition was observed at 
75 mg/kg (20.50 ± 3.56, 66.21%) (Fig. 2). Aspirin produced 
a greater inhibition (15.50 ± 2.89, 74.45%), however it was 
signiﬁcantly different (p < 0.05) from that of the extract (75 
mg/kg) within the same period.Haffner’s tail clip test
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Table 1 
Effect of extract of BM on carrageenan induced rat paw oedema.
Trt
Dose 
mg/kg
Increase in paw circumference (cm)
T0 T30 T60 T90 T120 T150 T180
BM 12.5 1.93 ± 0.03 2.18 ± 0.03 (53.7) 2.22 ± 0.01 (42.3) 2.25 ± 0.03 (44.8) 2.28 ± 0.01b (59.1) 2.28 ± 0.03c (23.9) 2.32 ± 0.01 (48.0)
BM 25 1.95 ± 0.02 2.15 ± 0.04 (63.0) 2.22 ± 0.01 (48.1) 2.25 ± 0.04 (48.2) 2.28 ± 0.05 (50.0) 2.3 ± 0.05 (23.9) 2.32 ± 0.03 (50.7)
BM 50 1.92 ± 0.04 2.05 ± 0.02a (75.9) 2.03 ± 0.05b (78.9) 2.13 ± 0.05a (69.0) 2.21 ± 0.05 (56.1) 2.25 ± 0.06 (28.3) 2.25 ± 0.08a(56.0)
BM 75 1.97 ± 0.05 2.08 ± 0.07 (81.4) 2.07 ± 0.03ª (82.7) 2.07 ± 0.03a (84.5) 2.15 ± 0.04a (74.2) 2.22 ± 0.05 (47.8) 2.32 ± 0.04b(66.7)
BM 100 1.74 ± 0.02 2.33 ± 0.04 (-9.3) 2.13 ± 0.03 (25.0) 2.33 ± 0.06 (-1.7) 2.4 ± 0.05 (0.0) 2.29 ± 0.09 (-19.6) 2.3 ± 0.05 (25.33)
Indn 10 1.92 ± 0.05 2.14 ± 0.08 (59.3) 2.18 ± 0.06 (50.0 ) 2.18 ± 0.06 (55.2) 2.13 ± 0.05b (68.2) 2.05 ± 0.03 (71.7) 2.02 ± 0.01c (86.7)
D.W 10ml/kg 1.78 ± 0.03 2.32 ± 0.05 2.30 ± 0.07 2.36 ± 0.1 2.44 ± 0.1 2.24 ± 0.1 2.53 ± 0.15
Figures in parenthesis represent percentage inhibition of edema development. 
Trt, Treatments; Indn, Indomethacin; D.W, Distilled water; BM, Blepharis maderaspatensis. Values are expressed as mean ± SEM, n =6. 
ap < 0.05. 
bp < 0.01. 
cp < 0.0001 compared to the control.
Table 2 
Effect of extract of BM on xylene induced edema in mice.
Treatment Dose (mg/kg) Ear swelling (g) Inhibition (%)
BM 12.5 0.025 ± 0.004 12.84
BM 25 0.002 ± 0.004a 21.40
BM 50 0.004 ± 0.004b 62.65
BM 75 0.009 ± 0.002a 30.74
BM 100 0.018 ± 0.002a -37.98
Dexamethasone 10 0.007 ± 0.003a 50.20
Distilled water 10 ml/kg 0.013 ± 0.006 _
BM, Blepharis maderaspatensis. Values are expressed as mean ± SEM, n = 6.  
ap <  0.05. 
bp < 0.01 compared to the control..
Fig. 2 -Effect of Blepharis maderaspatensis on mouse writhing 
test in mice. Values are expressed as mean ± SEM (n=6).  
*p < 0.05 compared to the control.
Haffner’s tail clip test.Haffner’s tail clip t.Haffner’s tail clip 
The effect of BM on the  tail clip test is shown in Table 3. 
The animals of the control group elicited reactions towards 
clip removal with pre-treatment latency being 4.43 ± 1.13 s 
and post-treatment latency being 5.79 ± 2.74 s. BM showed 
a significant (p < 0.05) dose-dependent increase in reaction 
latency. Maximum inhibition was produced at 75 mg/kg 
(15.81%). This effect was however less than that elicited by 
morphine (75.67%) at 10 mg/kg.
Fig. 1 - The effects of Blepharis maderaspatensis and 
indomethacin on rat’s hind paw edema induced by (a) 
histamine and (b) serotonin. Data represented as mean ± 
S.E.M (n=6). *p < 0.01. **p < 0.0001 (Two-way ANOVA followed 
by Bonferroni’s test).
Quantitaive analysis
The total phenolic and flavonoid content of the extract were 
88.73 ± 0.26 and 221.02 ± 0.004 respectively.
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Discussion
Modern medicine has gained immensely from the research 
of natural products as a number of the therapeutic drugs 
currently in use have been derived from pharmacologically 
active agents obtained from plants (Shu, 1998). However, in 
spite of this progress, the potential of higher plants as sources 
for new drugs is still largely unexplored.There is also an urgent 
need for effective anti-inflammatory and anti-nociceptive 
agents in medicine.
The result from the acute toxicity test carried out in 
this work indicated that the ethanol extract of Blepharis 
maderaspatensis (L.) B. Heyne ex Roth, Acanthaceae, has low 
oral toxicity as the 5 g/kg dose did not cause death in the 
animals even after seven days of administration.
The evaluation of the anti-inflammatory activity of B. 
maderaspatensis in this study was carried out using the 
carrageenan, histamine, serotonin and xylene-induced 
edema tests. It has been reported that the carrageenan-
induced rat paw model is a suitable in vivo model to study 
anti-inflammatory effects of natural products since it involves 
several mediators (Woldesellassie et al., 2011). Three phases 
have been postulated for carrageenan induced edema and 
these include; the initial phase (between 0 and 1.5 h) which 
is attributed to the action mediators such as histamine and 
serotonin; a second phase (1.5-2.5 h) mediated by bradykinin 
and a third phase (2.5-6 h) mediated by prostaglandins (Di 
Rosa et al., 1971; Suba et al., 2005). In this investigation, B. 
maderaspatensis showed significant inhibition of rat paw edema 
in the initial phase. This suggests that the extract (75 mg/kg, 
p.o.) plays an important role as a protective factor against 
carrageenan-induced acute inflammation and possibly acts 
by inhibiting the release of/ and the action of histamine and/
or serotonin.
Histamine and serotonin are potent vasodilator substances 
and are known to increase vascular permeability (Skidmore 
and Whitehouse, 1967). In order to confirm the results obtained 
from the carrageenan-induced edema test, the effect of the 
extract at the most effective concentration (75 mg/kg) was 
Table 3 
Effect of BMon Haffner’s tail clip reflex in mice.
Treatment
Dose  
mg/kg Pre-treatment(s)
Post-
treatment(s) % Inhibition
BM 12.5 3.35 ± 0.69  5.39 ± 1.14a 3.60
BM 25 3.49 ± 0.54  6.65 ± 1.43a 5.59
BM 50 2.89 ± 1.18 10.22 ± 3.14a 12.83
BM 75 3.20 ± 0.70a 12.18 ± 2.50a 15.81
BM 100 2.86 ± 0.55a  4.81 ± 0.53a 3.41
Morphine 10 5.96 ± 0.96 46.85 ± 7.56a 75.67
Distilled 
water
10 ml/kg 4.43 ± 1.13 5.79 ± 2.74 2.45
BM, Blepharis maderaspatensis. Values are expressed as mean ± SEM  
(n = 6). 
investigated using histamine and serotonin-induced edema 
models. The results showed that the extract effectively 
suppressed the edema produced by histamine but had a low 
effect on the edema produced by serotonin indicating that the 
extract exhibits its anti-inflammatory action by inhibiting the 
synthesis, release or action of histamine. 
The xylene-induced edema model is useful for the screening 
of anti-inflammatory agents. It is characterized by fluid 
accumulation and edema. Suppression of this response is taken 
as an indication of antiphlogistic effect (Atta and Alkofahi, 
1998). The effectiveness of B. maderaspatensis (50 mg/kg, p.o.) 
in this model may suggest the inhibition of phospholipase A 
which is involved in the pathophysiology of inflammation due 
to xylene (Lin et al., 1992).
In this study, the anti-nociceptive activity of B. maderaspat-
ensis was investigated using the mouse writhing and Haffner’s 
tail clip tests. The mouse writhing test is used for the evalu-
ation of peripherally acting drugs and the induction of pain 
occurs by the release of endogenous substances as well as 
other pain mediators such as arachidonic acid via cyclooxygen-
ase, and prostaglandin biosynthesis (Franzotti et al., 2000). The 
dose-dependent inhibition of writhing of the extract observed 
in this study, suggests a peripherally mediated anti-nociceptive 
activity based on the association of the model with stimulation 
of peripheral receptors (Bentley et al., 1983).
The tail clip test is a confirmatory test to show the centrally 
acting component of pain mechanism (Richardson et al., 
1998). Centrally acting anti-nociceptive drugs are known to 
elevate the pain threshold of rodents to pressure and heat 
(Singh and Majumdar, 1995). In this study, B. maderaspatensis 
extract elicited a very low activity (< 20%). This suggests that 
the extract does not have centrally acting anti-nociceptive 
properties.
The results obtained from the anti-inflammatory and anti-
nociceptive tests suggest that B. maderaspatensis is effective 
against inflammatory and nociceptive pains with a more 
pronounced effect in the former. It was also observed that in 
most of the models investigated, the highest inhibtion was at 
75 mg/kg after which there was a reduction in activity. This 
may be due to the filling of the opioid receptors (Bentley et 
al., 1983).
Previous studies have shown that anti-inflammatory and 
analgesic effects can be a result of the high polyphenol content 
of plants especially phenolics and flavonoids (Handa et al., 
1992; Orhan et al., 2007). Flavonoids are known to prevent the 
synthesis of prostaglandins. Biochemical investigations on 
the mechanism of action of flavonoids have shown that these 
compounds can inhibit a wide variety of enzymes. The release 
of arachidonic acid is closely related to the cyclooxygenase 
and 5-lipoxygenase enzyme systems (Middleton et al., 2000; 
Williams et al., 1995). The polyphenols present in this plant 
may be responsible for the observed anti-inflammatory and 
analgesic activities.
In conclusion, of the present study confirmed that B. 
maderaspatensis possesses significant anti-inflammatory 
and analgesic activities. The results also support the use of 
the plant in the treatment of inflammation-related diseases 
traditionally.
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